The β-thal short kit was more versatile than the sickle cell short kit for screening for haemoglobinopathies in newborns in our population.
No takes yet. Share an insight, caveat, or question.
Upadhye et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: